Related Experiment Video
Updated: Aug 5, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Representation of melanoma depth staging with limited central section sampling: a retrospective simulation study
Katharina Pustelnik1, Philipp Tschandl1
1Department of Dermatology, Medical University of Vienna, Vienna, Austria.
Summary
A central melanoma tissue section accurately reflects Breslow thickness and T-stage compared to full processing. This supports retaining primary melanomas during neoadjuvant therapy to potentially boost immune response.
Area of Science:
- Dermatology
- Oncology
- Pathology
Background:
- Thick melanomas may benefit from retaining the primary lesion during neoadjuvant therapy to increase antigen load and enhance immune response.
- Assessing the accuracy of a single central tissue section versus full serial sectioning is crucial for this approach.
Purpose of the Study:
- To evaluate if a central section of melanoma specimen accurately represents Breslow thickness and ulceration compared to complete serial sectioning.
- To determine the feasibility of using a central section for staging and treatment planning in melanoma.
Main Methods:
- Retrospective analysis of 78 invasive melanomas from 76 patients.
- Digitization of histological slides and measurement of tumor thickness and ulceration across all sections.
- Comparison of measurements from the central section to the overall specimen.
Main Results:
- Median difference in Breslow thickness between central and maximum measurements was <0.2 mm (p < 0.001).
- 82.1% of cases showed thickness within 0.2 mm.
- Ulceration was detected in all 9 positive cases within the central section.
- T-stage remained unchanged in 93.6% of cases.
Conclusions:
- A central melanoma section provides Breslow thickness and T-stage comparable to full serial sectioning in most cases.
- Underestimation of thickness was noted only in thin melanomas.
- Findings support further research into retaining primary melanomas during neoadjuvant therapy to enhance treatment efficacy.

